Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: An in vitro study

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Anton, Lauren ^a   Merrill, David C ^a   Neves, Liomar A A ^a   Gruver, Courtney ^a   Moorefield, Cheryl ^a   Brosnihan, K Bridget ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ENDOGLIN; HUMAN PLACENTA LACTOGEN; LACTATE DEHYDROGENASE; VASCULOTROPIN RECEPTOR 1; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN I (1 7); ANGIOTENSIN I (1-7); FLT1 PROTEIN, HUMAN; ISOPROTEIN; PEPTIDE FRAGMENT; PLACENTA LACTOGEN; VASCULOTROPIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PREECLAMPSIA; PREGNANCY; CELL CULTURE; CHEMISTRY; CHORION VILLUS; DOWN REGULATION; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PLACENTA; PLACENTA CIRCULATION; SOLUBILITY; VASCULARIZATION;

ADULT; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINS; CELLS, CULTURED; CHORIONIC VILLI; DOWN-REGULATION; FEMALE; HUMANS; MIDDLE AGED; PEPTIDE FRAGMENTS; PLACENTA; PLACENTAL CIRCULATION; PLACENTAL LACTOGEN; PRE-ECLAMPSIA; PREGNANCY; PROTEIN ISOFORMS; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 78049373054     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-135     Document Type: Article

References (42)

1. The Working Group on High Blood Pressure in Pregnancy. National High Blood Pressure Education Program (NHPEP) Working group report on high blood pressure in pregnancy. US Dept. Health and Human Services 1991, 91-3029. 1-46, The Working Group on High Blood Pressure in Pregnancy. National High Blood Pressure Education Program (NHPEP).
2. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9-22.
3. Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res 1999, 253:117-130. 10.1006/excr.1999.4707, 10579917.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658. 151901, 12618519.
5. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649. 10.1038/nm1429, 16751767.
6. Fisher SJ, Roberts JM. Defects in placentation and placental perfusion. Chesley's Disorders in Pregnancy 1999, 377-394. Stanford: Appleton & Lange, Lindheimer M, Roberts JM, Cunningham FG, 2.
7. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002, 9:147-160.
8. Taylor RN, Roberts JM. Endothelial cell dysfunction. Chesley's Hypertensive Disorders in Pregnancy 1999, 395-429. Stanford: Appleton & Lange, Lindheimer M, Roberts JM, Cunningham FG, 2.
9. Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993, 90:10705-10709. 10.1073/pnas.90.22.10705, 47846, 8248162.
10. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992, 267:19027-19030.
11. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Buhring HJ, Bernabeu C, van Mourik JA, Letarte M. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992, 4:83-92. 10.1093/intimm/4.1.83, 1371694.
12. St-Jacques S, Forte M, Lye SJ, Letarte M. Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 1994, 51:405-413. 10.1095/biolreprod51.3.405, 7528549.
13. Nasjletti A, Masson GMC. Studies on angiotensinogen formation in a liver perfusion system. Circ Res [Suppl II] 1972, 30:187-202.
14. Tewksbury DA. Angiotensinogen -- Biochemistry and Molecular Biology. Hypertension: Pathophysiology, Diagnosis and Management 1990, 1197-1216. New York: Raven Press, Laragh JH, Brenner BM.
15. Chen Y, Naftilan AJ, Oparil S. Androgen-dependent angiotensinogen and renin messenger RNA expression in hypertensive rats. Hypertension 1992, 19:456-463.
16. Rubattu S, Quimby FW, Sealey JE. Tissue renin and prorenin increase in female cats during the reproductive cycle without commensurate changes in plasma, amniotic or ovarian follicular fluid. J Hypertens 1991, 9:525-535. 10.1097/00004872-199106000-00008, 1653292.
17. Glorioso N, Atlas SA, Laragh JH, Jewelewicz R, Sealey JE. Prorenin in high concentrations in human ovarian follicular fluid. Science 1986, 233:1422-1424. 10.1126/science.3529392, 3529392.
18. Howard RB, Pucell AG, Bumpus FM, Husain A. Rat ovarian renin: Characterization and changes during the estrous cycle. Endocrinology 1988, 123:2331-2340. 10.1210/endo-123-5-2331, 3139395.
19. Brosnihan KB, Santos RAS, Block CH, Schiavone MT, Welches WR, Chappell MC, Khosla MC, Greene LJ, Ferrario CM. Biotransformation of angiotensins in the central nervous system. Ther Res 1988, 9:48-59.
20. Ferrario CM, Chappell MC. A new myocardial conversion of angiotensin I. Curr Opin Cardiol 1994, 9:520-526. 10.1097/00001573-199409000-00004, 7987030.
21. Merrill DC, Karoly M, Chen K, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) in normal and preeclamptic pregnancy. Endocrine 2002, 18:239-245. 10.1385/ENDO:18:3:239, 12450315.
22. Valdes G, Germain AM, Corthorn J, Berrios C, Foradori AC, Ferrario CM, Brosnihan KB. Urinary vasodilator and vasoconstrictor angiotensins during menstrual cycle, pregnancy, and lactation. Endocrine 2001, 16:117-122. 10.1385/ENDO:16:2:117, 11887932.
23. Anton L, Merrill DC, Neves LAA, Stovall K, Gallagher PE, Diz DI, Moorefield C, Gruver C, Ferrario CM, Brosnihan KB. Activation of local chorionic villi angiotensin II levels but not angiotensin (1-7) in preeclampsia. Hypertension 2008, 51:1066-1072. 10.1161/HYPERTENSIONAHA.107.103861, 2705753, 18259034.
24. Williams B. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy. Miner Electrolyte Metab 1998, 24:400-405. 10.1159/000057401, 9930379.
25. Otani A, Takagi H, Suzuma K, Honda Y. Angiotensin II potentiates vascular endothelial growth factor--induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998, 82:619-628.
26. Chua CC, Hamdy RC, Chua BH. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. Biochim Biophys Acta 1998, 1401:187-194. 10.1016/S0167-4889(97)00129-8, 9531974.
27. Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyama S, Iwasaka T. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 2001, 88:22-29.
28. Amaral SL, Linderman JR, Morse MM, Greene AS. Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation 2001, 8:57-67.
29. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004, 95:884-891. 10.1161/01.RES.0000147365.86159.f5, 15472115.
30. Soothill PW, Nicolaides KH, Rodeck CH, Campbell S. Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther 1986, 1:168-175. 10.1159/000262264, 3454532.
31. Fujikura T, Yoshida J. Blood gas analysis of placental and uterine blood during cesarean delivery. Obstet Gynecol 1996, 87:133-136. 10.1016/0029-7844(95)00300-2, 8532249.
32. Zhou CC, Ahmad S, Mi T, Xia L, Abbasi S, Hewett PW, Sun C, Ahmed A, Kellems RE, Xia Y. Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 2007, 100:88-95. 10.1161/01.RES.0000254703.11154.18, 17158338.
33. Anton L, Merrill DC, Neves LA, Brosnihan KB. Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 2007, 32:212-218. 10.1007/s12020-007-9022-1, 18008188.
34. Machado RD, Santos RA, Andrade SP. Mechanisms of angiotensin-(1-7)-induced inhibition of angiogenesis. American Journal of Physiology - Regulatory Integrative & Comparative Physiology 2001, 280:R994-R1000.
35. Machado RD, Santos RA, Andrade SP. Opposing actions of angiotensins on angiogenesis. Life Sci 2000, 66:67-76. 10.1016/S0024-3205(99)00562-7, 10658925.
36. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, Gallagher PE. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res 2007, 67:2809-2815. 10.1158/0008-5472.CAN-06-3614, 17363603.
37. Schiavone MT, Santos RAS, Brosnihan KB, Khosla MC, Ferrario CM. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 1988, 85:4095-4098. 10.1073/pnas.85.11.4095, 280369, 3375255.
38. Rowe BP, Saylor DL, Speth RC, Absher DR. Angiotensin-(1-7) binding at angiotensin II receptors in the rat brain. Regul Pept 1995, 56:139-146. 10.1016/0167-0115(95)00010-9, 7652190.
39. Tallant EA, Lu X, Weiss RB, Chappell MC, Ferrario CM. Bovine aortic endothelial cells contain an angiotensin-(1-7) receptor. Hypertension 1997, 29:388-392.
40. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683. 10.1056/NEJMoa031884, 14764923.
41. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De MM, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, Vandendriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001, 7:575-583. 10.1038/87904, 11329059.
42. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003, 188:177-182. 10.1067/mob.2003.111, 12548214.